Manufacturers say Rantac safe for consumption, NDMA within permissible limits
Earlier this week on September 23, the Drug Controller General of India (DCGI) asked state regulators to direct manufacturers of Ranitidine API to take measures to verify their products for the presence of NDMA, in order to ensure safety of consumers/patients.